Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer
Author:
Funder
Sanofi
Janssen
Amgen
Takeda
Astellas
Bayer
Gilead
Ferring
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference46 articles.
1. Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials;Templeton;Ann Oncol,2013
2. Targeting continued androgen receptor signaling in prostate cancer;Massard;Clin Cancer Res,2011
3. Evolution of androgen receptor targeted therapy for advanced prostate cancer;Wong;Nat Rev Clin Oncol,2014
4. Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer;Smith;J Clin Oncol,2005
5. The development of androgen-independent prostate cancer;Feldman;Nat Rev Cancer,2001
Cited by 65 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapy resistance in prostate cancer: mechanism, signaling and reversal strategies;Exploration of Targeted Anti-tumor Therapy;2024-08-29
2. Stat5 induces androgen receptor ( AR ) gene transcription in prostate cancer and offers a druggable pathway to target AR signaling;Science Advances;2024-03
3. Utility of green chemistry for sustainable fluorescence derivatization approach for spectrofluorimetric quantification of Darolutamide as antineoplastic drug in pharmaceutical formulation and spiked human plasma;Luminescence;2024-03
4. A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532);European Urology Oncology;2024-01
5. Assessment of Prostate and Bladder Cancer Genomic Biomarkers Using Artificial Intelligence: a Systematic Review;Current Urology Reports;2023-12-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3